| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.04B | +38.7% |
| Cost of Revenue | $288.1M | +41.5% |
| Gross Profit | $749.5M | +37.7% |
| R&D Expense | $306.3M | +30.2% |
| SG&A Expense | $181.9M | +16.6% |
| Operating Income | $135.6M | +116.6% |
| Pre-tax Income | $182.4M | +78.3% |
| Income Tax | -$231.7M | -1787.0% |
| Net Income | $414.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.04B | +31.9% |
| Accounts Receivable | $162.8M | +26.3% |
| Current Assets | $1.44B | +30.4% |
| Total Assets | $1.99B | +53.0% |
| Current Liabilities | $551.1M | +30.5% |
| Total Liabilities | $645.2M | +35.2% |
| Stockholders' Equity | $1.35B | +63.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $387.8M | +35.8% |
| Capital Expenditures | $18.1M | +49.4% |
| Investing Cash Flow | -$107.7M | +50.5% |
| Financing Cash Flow | -$29.5M | +1.5% |
| Free Cash Flow | $369.7M | +35.2% |
| +367.5% |
| EPS (Basic) | $9.05 | +343.6% |
| EPS (Diluted) | $8.57 | +355.9% |